The Valley Desk

NCT06627413 · Interventional trial

Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder

Overall registry status Completed

Phase 1

Conditions Schizophrenia or Schizoaffective

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov